Resources

• Mitochondrial Protein Mass Spectrometry: What Data Can You Get?

A technical-results guide to what data mitochondrial protein mass spectrometry can provide, covering identification, quantification, report files, and phenotype-assay exclusions.

• Mitochondrial Proteomics Service: What to Know Before Starting a Project

A project-planning guide to what to confirm before starting a mitochondrial proteomics service project, covering sample amounts, DDA/DIA paths, timeline, and scope limits.

• Mitochondrial Proteomics for Oxidative Stress and Respiratory Chain Injury

An application guide to mitochondrial proteomics in oxidative stress and respiratory chain injury research, mapping respiratory-chain and redox protein changes with clear limits versus ROS and functional assays.

• How Mitochondrial Proteomics Reveals Protein Changes After Drug Treatment

An application-focused guide on using mitochondrial proteomics to detect protein changes after drug treatment, covering what a treated-versus-control comparison reveals, its limits versus functional and safety assays, and how to design dose and time.

• How to Compare Mitochondrial Protein Changes Across Aging Stages

An application-focused guide on comparing mitochondrial protein changes across aging stages, covering what a multi-stage comparison reveals, its limits versus functional assays, and how to design ordered age groups for interpretable trends.

• How Mitochondrial Proteomics Reveals Mitochondrial Dysfunction in Neurodegenerative Disease

An application guide to mitochondrial proteomics in neurodegenerative disease, mapping protein-level dysfunction patterns across pathway groups with clear limits versus functional assays.

• Mitochondrial Protein Analysis for Tumor Metabolism and Candidate Protein Prioritization

An application guide to mitochondrial protein analysis in tumor metabolism, focused on ranking differential proteins into a defensible candidate shortlist with explicit prioritization criteria.

• Mitochondrial Proteomics for Comparing Drug-Sensitive and Drug-Resistant Cancer Models

An application-focused guide on using mitochondrial proteomics to compare drug-sensitive and drug-resistant cancer models, covering what it reveals, its limits, and study design for a defensible comparison.

• How Mitochondrial Proteomics Reveals Oxidative Phosphorylation Changes in Cancer Cells

An application guide to using mitochondrial proteomics for oxidative phosphorylation changes in cancer cells, mapping Complex I to V subunit abundance across study arms with clear activity limits.

• Mitochondrial Proteomics in Cancer Metabolism: Mapping Metabolic Reprogramming and Therapy Response

An application guide to mitochondrial proteomics in cancer metabolism, covering fit assessment for metabolic reprogramming and therapy-response studies, design notes, and interpretation limits.